BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9657156)

  • 1. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion.
    DePace AH; Santoso A; Hillner P; Weissman JS
    Cell; 1998 Jun; 93(7):1241-52. PubMed ID: 9657156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion.
    Osherovich LZ; Weissman JS
    Cell; 2001 Jul; 106(2):183-94. PubMed ID: 11511346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supporting the structural basis of prion strains: induction and identification of [PSI] variants.
    King CY
    J Mol Biol; 2001 Apr; 307(5):1247-60. PubMed ID: 11292339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of prion transmission barriers by mutational control of amyloid conformations.
    Chien P; DePace AH; Collins SR; Weissman JS
    Nature; 2003 Aug; 424(6951):948-51. PubMed ID: 12931190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions.
    Parham SN; Resende CG; Tuite MF
    EMBO J; 2001 May; 20(9):2111-9. PubMed ID: 11331577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein.
    Chernoff YO; Galkin AP; Lewitin E; Chernova TA; Newnam GP; Belenkiy SM
    Mol Microbiol; 2000 Feb; 35(4):865-76. PubMed ID: 10692163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins.
    Halfmann R; Alberti S; Krishnan R; Lyle N; O'Donnell CW; King OD; Berger B; Pappu RV; Lindquist S
    Mol Cell; 2011 Jul; 43(1):72-84. PubMed ID: 21726811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Candida albicans Sup35p protein (CaSup35p): function, prion-like behaviour and an associated polyglutamine length polymorphism.
    Resende C; Parham SN; Tinsley C; Ferreira P; Duarte JAB; Tuite MF
    Microbiology (Reading); 2002 Apr; 148(Pt 4):1049-1060. PubMed ID: 11932450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Yarrowia lipolytica orthologs of Sup35p assemble into thioflavin T-negative amyloid fibrils.
    Kabani M; Melki R
    Biochem Biophys Res Commun; 2020 Aug; 529(3):533-539. PubMed ID: 32736670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.
    Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth.
    Watzky MA; Morris AM; Ross ED; Finke RG
    Biochemistry; 2008 Oct; 47(40):10790-800. PubMed ID: 18785757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of the asparagine- and glutamine-rich yeast prions into protein fibrils.
    Bousset L; Savistchenko J; Melki R
    Curr Alzheimer Res; 2008 Jun; 5(3):251-9. PubMed ID: 18537542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of conformational flexibility in prion propagation and maintenance for Sup35p.
    Scheibel T; Lindquist SL
    Nat Struct Biol; 2001 Nov; 8(11):958-62. PubMed ID: 11685242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation.
    Alexandrov IM; Vishnevskaya AB; Ter-Avanesyan MD; Kushnirov VV
    J Biol Chem; 2008 May; 283(22):15185-92. PubMed ID: 18381282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into intragenic and extragenic effectors of prion propagation using chimeric prion proteins.
    True HL; Kalastavadi T; Tank EM
    Prion; 2008; 2(2):45-7. PubMed ID: 19098443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prions of yeast as heritable amyloidoses.
    Wickner RB; Taylor KL; Edskes HK; Maddelein ML; Moriyama H; Roberts BT
    J Struct Biol; 2000 Jun; 130(2-3):310-22. PubMed ID: 10940235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct amino acid compositional requirements for formation and maintenance of the [PSI⁺] prion in yeast.
    MacLea KS; Paul KR; Ben-Musa Z; Waechter A; Shattuck JE; Gruca M; Ross ED
    Mol Cell Biol; 2015 Mar; 35(5):899-911. PubMed ID: 25547291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scrambled prion domains form prions and amyloid.
    Ross ED; Baxa U; Wickner RB
    Mol Cell Biol; 2004 Aug; 24(16):7206-13. PubMed ID: 15282319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein-only theory and the yeast Saccharomyces cerevisiae: the prions and the propagons.
    Fernandez-Bellot E; Cullin C
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1857-78. PubMed ID: 11766884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.
    Kochneva-Pervukhova NV; Paushkin SV; Kushnirov VV; Cox BS; Tuite MF; Ter-Avanesyan MD
    EMBO J; 1998 Oct; 17(19):5805-10. PubMed ID: 9755180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.